November 27, 2021
Article
Lomecel-B (Longeveron) is an investigational allogeneic, bone marrow-derived medicinal signaling cell medication that is being evaluated in a phase 2 trial.
November 26, 2021
Video
Ray Tancredi, RPh, MBA, divisional VP of specialty pharmacy development and brand Rx/vaccine purchasing at Walgreens, discusses key drugs in development that are slated to launch in 2022.
November 25, 2021
Ocrelizumab is indicated for the treatment of relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting MS, and active secondary progressive disease, in adults.
November 24, 2021
Are you curious about what other pharmacists earn? About the job satisfaction and compensation of pharmacists in other geographic areas? So are we!
November 23, 2021
Investigators have developed an immunotherapy that is a potential option for children with hard-to-treat brain cancer.
Ten quiz questions to assess your knowledge on common symptoms and treatments for HIV.
November 22, 2021
The study’s identification of a network of possible candidate genes to carefully control for mutations could alter the future clinical implementation of CRISPR.
November 19, 2021
The Build Back Better bill include an authorization for the government to negotiate lower drug prices.
November 18, 2021
Pembrolizumab demonstrated a statistically significant improvement in disease-free survival, reducing the risk of disease recurrence or death by 32% compared to placebo.
Olumiant shows favorable long-term safety profile in rheumatoid arthritis.
